Cargando…

Implementing personalized medicine in diabetic kidney disease: Stakeholders' perspectives

The promise of personalized medicine to deliver “the right treatments at the right time to the right person” is the next frontier in healthcare. However, to implement personalized medicine in chronic diseases such as diabetes mellitus and diabetic kidney disease (DKD), a number of different aspects...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Vries, Jeroen K., Levin, Adeera, Loud, Fiona, Adler, Amanda, Mayer, Gert, Pena, Michelle J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2018
Materias:	Precision Medicine in Diabetic Kidney Disease. Guest Editor: Hiddo J. L. Heerspink
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220793/ https://www.ncbi.nlm.nih.gov/pubmed/30294955 http://dx.doi.org/10.1111/dom.13412

Ejemplares similares

Treating diabetic complications; from large randomized clinical trials to precision medicine
por: Heerspink, Hiddo J. L., et al.
Publicado: (2018)

Precision medicine in diabetes and diabetic kidney disease: Regulatory considerations
por: Mol, Peter G. M., et al.
Publicado: (2018)

New clinical trial designs for establishing drug efficacy and safety in a precision medicine era
por: Heerspink, Hiddo J. L., et al.
Publicado: (2018)

Diabetic nephropathy as the cause of end-stage kidney disease reported on the medical evidence form CMS2728 at a single center
por: Yuan, Christina M., et al.
Publicado: (2017)

The large spectrum of renal disease in diabetic patients
por: Bermejo, Sheila, et al.
Publicado: (2017)

Sodium-glucose cotransporter 2 inhibitors for diabetic kidney disease: a primer for deprescribing
por: Li, Jiahua, et al.
Publicado: (2019)

The risk for urinary tract infections with sodium-glucose cotransporter 2 inhibitors: no longer a cause of concern?
por: Sarafidis, Pantelis A, et al.
Publicado: (2019)

Specific impact of past and new major cardiovascular events on acute kidney injury and end-stage renal disease risks in diabetes: a dynamic view
por: Pinier, Cédric, et al.
Publicado: (2019)

Diabetes mellitus: a single cardiorenal syndrome umbrella
por: Rodríguez, Eva, et al.
Publicado: (2019)

Humoral Responses in the Omicron Era Following 3-Dose SARS-CoV-2 Vaccine Series in Kidney Transplant Recipients
por: McEvoy, Caitríona M., et al.
Publicado: (2022)

Nephrotic syndrome and adrenal insufficiency caused by a variant in SGPL1
por: Linhares, Natália Duarte, et al.
Publicado: (2018)

Patient Survey of current water Intake practices in autosomal dominant Polycystic kidney disease: the SIPs survey
por: El-Damanawi, Ragada, et al.
Publicado: (2017)

Sustainable Oral Healthcare: A Joint Stakeholder Approach
por: Martin, Nicolas, et al.
Publicado: (2022)

Successful Implementation of an Increased Viral Risk Donor Waiting List for Preconsented Kidney Transplant Candidates in Victoria, Australia
por: Lee, Darren, et al.
Publicado: (2021)

4089 Clinical Implementation of Monte Carlo Dose Calculation for Patient-Specific Radiotherapy Quality Assurance
por: Parenica, Holly Marie, et al.
Publicado: (2020)

92811 Implementation of the Fitness, Lifestyle, and Optimal Wellness (FLOW) Program and Its Associated Health Outcomes
por: Brake, Daniel, et al.
Publicado: (2021)

97856 Implementation of DPYD and UGT1A1 pharmacogenetic testing to guide chemotherapy dosing
por: Varughese, Lisa A., et al.
Publicado: (2021)

Early Treatment With Olmesartan Prevents Juxtamedullary Glomerular Podocyte Injury and the Onset of Microalbuminuria in Type 2 Diabetic Rats
por: Sofue, Tadashi, et al.
Publicado: (2012)

Interdependency of Cystathione γ-Lyase and Cystathione β-Synthase in Hydrogen Sulfide–Induced Blood Pressure Regulation in Rats
por: Roy, Alexander, et al.
Publicado: (2012)

Prescription of renin‐angiotensin‐aldosterone system inhibitors (RAASi) and its determinants in patients with advanced CKD under nephrologist care
por: Pecoits‐Filho, Roberto, et al.
Publicado: (2019)

Range and Consistency of Cardiovascular Outcomes Reported by Clinical Trials in Kidney Transplant Recipients: A Systematic Review
por: Wilson, Gregory J., et al.
Publicado: (2022)

Patient kidney disease knowledge remains inadequate with standard nephrology outpatient care
por: Gray, Nicholas A., et al.
Publicado: (2016)

Chronic kidney disease hotspots in developing countries in South Asia
por: Abraham, Georgi, et al.
Publicado: (2016)

The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness
por: Runesson, Björn, et al.
Publicado: (2016)

Loin pain hematuria syndrome
por: Zubair, Adeel S., et al.
Publicado: (2016)

Multidisciplinary care improves clinical outcome and reduces medical costs for pre-end-stage renal disease in Taiwan
por: Chen, Yue-Ren, et al.
Publicado: (2014)

Does lower urine-specific gravity predict decline in renal function and hypernatremia in older adults exposed to psychotropic medications? An exploratory analysis
por: Sajadi, Sahar, et al.
Publicado: (2016)

Safety concerns about intravenous iron therapy in patients with chronic kidney disease
por: Del Vecchio, Lucia, et al.
Publicado: (2016)

Can we routinely measure patient involvement in treatment decision-making in chronic kidney care? A service evaluation in 27 renal units in the UK
por: Durand, Marie-Anne, et al.
Publicado: (2016)

SEROLOGICAL MARKERS OF VIRAL, SYPHILITIC AND TOXOPLASMIC INFECTION IN CHILDREN AND TEENAGERS WITH NEPHROTIC SYNDROME: CASE SERIES FROM MATO GROSSO STATE, BRAZIL
por: Soares, Silvania França da Silva, et al.
Publicado: (2014)

Consequences of morbid obesity on the kidney. Where are we going?
por: Navarro Díaz, Maruja
Publicado: (2016)

HIV and kidney diseases: 35 years of history and consequences
por: Campos, Pedro, et al.
Publicado: (2016)

Two brothers with identical variants of the CLCN5 gene—one developing Dent’s disease
por: Fischer, Anne Sophie, et al.
Publicado: (2018)

Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic
por: Clissold, Rhian L, et al.
Publicado: (2018)

Late-onset Bartter syndrome type II
por: Gollasch, Benjamin, et al.
Publicado: (2017)

Potential and pitfalls in the genetic diagnosis of kidney diseases
por: Kesselheim, Anne, et al.
Publicado: (2017)

Rare diseases, rare presentations: recognizing atypical inherited kidney disease phenotypes in the age of genomics
por: Ars, Elisabet, et al.
Publicado: (2017)

Should eculizumab be discontinued in patients with atypical hemolytic uremic syndrome?
por: Rodriguez, Eva, et al.
Publicado: (2017)

Current evidence on the discontinuation of eculizumab in patients with atypical haemolytic uraemic syndrome
por: Macia, Manuel, et al.
Publicado: (2017)

Sickle cell disease and albuminuria: recent advances in our understanding of sickle cell nephropathy
por: Audard, Vincent, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_52nhtq56550abkcbpce9fk9ud4